Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress

<p>NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that a late-breaking abstract reporting the use of rigosertib in patients with recessive dystrophic epidermolysis bullosa (RDEB) associated with advanced/metastatic squamous cell […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/onconova-therapeutics-to-present-a-late-breaking-abstract-on-rigosertib-at-the-2023-eadv-congress/">Onconova Therapeutics to Present a Late-Breaking Abstract on Rigosertib at the 2023 EADV Congress</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>